KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Non-Current Assets (2016 - 2025)

AbbVie (ABBV) has disclosed Other Non-Current Assets for 14 consecutive years, with $10.7 billion as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 17.27% to $10.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.7 billion through Dec 2025, up 17.27% year-over-year, with the annual reading at $10.7 billion for FY2025, 17.27% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $10.7 billion at AbbVie, up from $9.6 billion in the prior quarter.
  • The five-year high for Other Non-Current Assets was $10.7 billion in Q4 2025, with the low at $4.7 billion in Q3 2021.
  • Average Other Non-Current Assets over 5 years is $7.1 billion, with a median of $6.6 billion recorded in 2023.
  • Peak annual rise in Other Non-Current Assets hit 81.65% in 2021, while the deepest fall reached 0.68% in 2021.
  • Over 5 years, Other Non-Current Assets stood at $4.9 billion in 2021, then rose by 14.07% to $5.6 billion in 2022, then skyrocketed by 52.81% to $8.5 billion in 2023, then rose by 7.39% to $9.1 billion in 2024, then grew by 17.27% to $10.7 billion in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $10.7 billion, $9.6 billion, and $9.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.